Discover the complete record of transactions filed by Hanley Jr. Michael Conick, Directeur Commercial. Director active across 1 company, notably Aeglea BioTherapeutics, Inc.. In total, 1 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €19k. Activity tracked since 8 June 2022. The latest transaction was filed on 8 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Michael Conick Hanley Jr. is the Chief Commercial Officer at Aeglea BioTherapeutics, Inc. He is responsible for the commercial strategy and managing customer relationships. With a strong background in the industry, he plays a key role in developing strategies that support Aeglea's growth. His expertise is essential in achieving the organization's objectives.